OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in listeria-based cancer ...
Request for FDA Rolling Review submitted to FDA on January 30, 2026Non-Clinical and CMC BLA modules submitted to FDAAt FDA's ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
Backed by a $15 million investment, families, funders, and researchers unite to advance long-awaited breakthroughs against this deadly childhood bone cancer "This Break Through Cancer project brings a ...
Researchers published a new study, “Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution,” in Cell that they say solves the mystery of what drives the genomic ...
Scientists at St. Jude Children’s Research Hospital report that they have identified a way to improve CAR T-cell homing for osteosarcoma. Their study “Redirecting B7-H3.CAR T cells to chemokines ...
A major driver of the bone cancer osteosarcoma has been discovered by researchers from UCL, EMBL EBI and the Royal National Orthopaedic Hospital, providing insights that could help to predict cancer ...
Facebook on MSN
At 10 years old, she was diagnosed with osteosarcoma, a type of bone cancer, and had her affected bone replaced with an...
At 10 years old, she was diagnosed with osteosarcoma, a type of bone cancer, and had her affected bone replaced with an ...
KTALnews.com on MSN
Brenna Huckaby: Beating cancer to triumph at the Paralympics
Brenna Huckaby, a Louisiana native, turned her tragedy of being diagnosed with osteosarcoma and having her leg amputated at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results